116 related articles for article (PubMed ID: 14748875)
41. Severity of liver disease in hepatitis C infection contracted through injecting drug use.
Ostapowicz G; Bell SJ; Desmond PV
Aust N Z J Med; 1999 Dec; 29(6):776-81. PubMed ID: 10677121
[TBL] [Abstract][Full Text] [Related]
42. Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework.
Harris M; Rhodes T
Drug Alcohol Depend; 2013 Oct; 132(3):617-23. PubMed ID: 23664125
[TBL] [Abstract][Full Text] [Related]
43. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
[TBL] [Abstract][Full Text] [Related]
44. National Trend and Characteristics of Acute Hepatitis C among HIV-Infected Individuals: A Matched Case-Control Study-Taiwan, 2001-2014.
Lo YC; Tsai MS; Sun HY; Hung CC; Chuang JH
PLoS One; 2015; 10(10):e0139687. PubMed ID: 26439381
[TBL] [Abstract][Full Text] [Related]
45. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia.
Coupland H; White B; Bates A; Park JN; Iversen J; Maher L
Drug Alcohol Rev; 2019 Feb; 38(2):177-184. PubMed ID: 30652363
[TBL] [Abstract][Full Text] [Related]
46. Failure to Test and Identify Perinatally Infected Children Born to Hepatitis C Virus-Infected Women.
Kuncio DE; Newbern EC; Johnson CC; Viner KM
Clin Infect Dis; 2016 Apr; 62(8):980-5. PubMed ID: 26797211
[TBL] [Abstract][Full Text] [Related]
47. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
Liu Y; Liu Y; Zou X; Chen W; Ling L
BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
[TBL] [Abstract][Full Text] [Related]
48. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.
Bodsworth NJ; Cunningham P; Kaldor J; Donovan B
Genitourin Med; 1996 Apr; 72(2):118-22. PubMed ID: 8698359
[TBL] [Abstract][Full Text] [Related]
50. [Demographic profile of a person with symptomatic hepatitis C in Poland].
Kajko M; Slusarczyk J; Czarkowski M; Rosińska M
Przegl Epidemiol; 2012; 66(2):351-6. PubMed ID: 23101230
[TBL] [Abstract][Full Text] [Related]
51. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
Dore GJ; Hajarizadeh B
Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
[TBL] [Abstract][Full Text] [Related]
52. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J;
J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027
[TBL] [Abstract][Full Text] [Related]
53. The tattooing paradox: are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection?
Haley RW; Fischer RP
Arch Intern Med; 2003 May; 163(9):1095-8. PubMed ID: 12742809
[TBL] [Abstract][Full Text] [Related]
54. Surveillance for acute viral hepatitis--United States, 2005.
Wasley A; Miller JT; Finelli L;
MMWR Surveill Summ; 2007 Mar; 56(3):1-24. PubMed ID: 17363893
[TBL] [Abstract][Full Text] [Related]
55. A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection.
Balogun MA; Ramsay ME; Parry JV; Donovan L; Andrews NJ; Newham JA; McGarrigle C; Harris KA; Teo CG
Sex Transm Infect; 2003 Aug; 79(4):301-6. PubMed ID: 12902580
[TBL] [Abstract][Full Text] [Related]
56. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta.
Meky FA; Stoszek SK; Abdel-Hamid M; Selim S; Abdel-Wahab A; Mikhail N; El-Kafrawy S; El-Daly M; Abdel-Aziz F; Sharaf S; Mohamed MK; Engle RE; Emerson SU; Purcell RH; Fix AD; Strickland GT
Clin Infect Dis; 2006 Mar; 42(5):628-33. PubMed ID: 16447107
[TBL] [Abstract][Full Text] [Related]
57. Epidemiology of hepatitis C.
Alter MJ
Hepatology; 1997 Sep; 26(3 Suppl 1):62S-65S. PubMed ID: 9305666
[TBL] [Abstract][Full Text] [Related]
58. Estimate of vertical transmission of Hepatitis C virus in Pakistan in 2007 and 2012 birth cohorts.
Benova L; Awad SF; Abu-Raddad LJ
J Viral Hepat; 2017 Dec; 24(12):1177-1183. PubMed ID: 28662284
[TBL] [Abstract][Full Text] [Related]
59. Epidemiology of HCV infection.
Baldo V; Baldovin T; Trivello R; Floreani A
Curr Pharm Des; 2008; 14(17):1646-54. PubMed ID: 18673187
[TBL] [Abstract][Full Text] [Related]
60. Trends in testing behaviours for hepatitis C virus infection and associated determinants: results from population-based laboratory surveillance in Alberta, Canada (1998-2001).
Jayaraman GC; Lee B; Singh AE; Preiksaitis JK
J Viral Hepat; 2007 Apr; 14(4):249-54. PubMed ID: 17381716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
